Article metrics

Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)

 

Online download statistics by month:

Online download statistics by month: June 2022 to April 2023

AbstractFullPdf
Jun 202225652573143
Jul 20221138114465
Aug 202233033553
Sep 202218418142
Oct 202213814327
Nov 202215715331
Dec 202210910819
Jan 202314314225
Feb 202316416676
Mar 202310910234
Apr 2023939336
Total51305140551